Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis

The British paediatric Rheumatology Study Group

Research output: Contribution to journalArticlepeer-review

8 Citations (SciVal)


Objectives. Juvenile idiopathic arthritis (JIA) is a complex polygenic disorder. The encouraging outcome of anti-tumour necrosis factor (TNF) treatment, as well as serological studies, has implicated TNF and its receptors (TNFRI and TNFRII, or TNFRSF1B) in the pathogenesis of JIA. The purpose of this study was to investigate the exon 6 TNFRII single nucleotide polymorphism (SNP) in a well-defined UK cohort of JIA patients, using case-control association analysis. Methods. A total of 435 patients, spanning seven JIA subgroups, and 261 healthy individuals were screened for the polymorphism using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results. No significant differences were observed between the SNP allelic or genotypic frequencies of patients and controls, or between JIA subgroups. Conclusions. This TNFRII exon 6 SNP does not seem to be associated with susceptibility to JIA.

Original languageEnglish
Pages (from-to)462-465
Number of pages4
Issue number4
Publication statusPublished - 2002
Externally publishedYes


  • Complex genetic disease
  • Juvenile idiopathic arthritis
  • Single nucleotide polymorphism
  • Tumour necrosis factor receptor II

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)


Dive into the research topics of 'Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis'. Together they form a unique fingerprint.

Cite this